Olanzapine
PR/CT 0309/2014 (SC)
Approved small_molecule terminated
Quick answer
Olanzapine for Acute Agitation, Behavioural Emergency is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Acute Agitation, Behavioural Emergency
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated